ARCHIVES

Major Changes In NCI Drug screening Tumor Panels Approved

This article is from The Cancer Letter archive.

Vol. 08 No. 25 | June 18, 1982

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

In Brief: Abeloff, Fisher Lead ASCO; Henney Replaces Antman On Govt. Relations; Ultmann Retires

May 31, 1991

NCI appoints Robert Young chairman of the Board of Scientific Advisors, reappoints Ellen Sigal, and names 11 new members to board. Earnest Hawk to direct NCI Office of Centers, Training and Resources.

November 12, 2004

Two Phase II Studies of Ibrutinib Deliver High Response Rates

December 27, 2013

In Brief: Garb Raps “Hostility Of Executive Branch”; Hew Considers Allowing Grants For Industry

April 25, 1980

Complete List of Recommendations by Centers Committee

October 18, 1996